Fortrea is a contract research organization that runs clinical development and related services for biopharma and medical-device sponsors. Spun out of Labcorp, it supports trials from early development through late-phase studies, including clinical operations, data and patient-access solutions. Drug and device developers hire Fortrea to outsource trial execution rather than building full in-house clinical capacity.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 710.3 | — | -374.9 | — |
| Q3 2025 | 701.3 | — | -15.9 | — |
| Q4 2025 | 660.5 | — | -32.5 | — |
| Q1 2026 | 636.5 | — | -23.6 | — |
| Q2 2026 | 678.2 | -4.5% | -13.2 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: ChipMOS TECHNOLOGIES INC. (IMOS), Perdoceo Education Corporation (PRDO), Bitdeer Technologies Group (BTDR), SoundHound AI, Inc. (SOUN), Interface, Inc. (TILE), 1st Source Corporation (SRCE)